BRIEF-Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics

Jan 26 (Reuters) - Autolus Therapeutics PLC 6A3Ay.F:

  • AUTOLUS THERAPEUTICS PLC - UNIT ENTERS MASTER SERVICE AGREEMENT WITH AGC BIOLOGICS - SEC FILING

  • AUTOLUS THERAPEUTICS PLC: AGREEMENT FOR MANUFACTURE AND SUPPLY OF LENTIVIRAL VECTOR

  • AUTOLUS THERAPEUTICS PLC - AGREEMENT RUNS FOR TEN YEARS, TERMINABLE FOR DEFAULT - SEC FILING

  • AUTOLUS THERAPEUTICS PLC - UNDER DEAL, TO PURCHASE MINIMUM OF 14 BATCHES OF LENTIVIRAL VECTOR DURING FIRST 2 CALENDAR YEARS - SEC FILING

  • AUTOLUS THERAPEUTICS PLC - TO PURCHASE MINIMUM EUR 25 MILLION OF PRODUCTS AND SERVICES - SEC FILING

Further company coverage: [6A3Ay.F]


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.